A2M - Mark Nuijten

Bridging our International Know-how and Experience in Market Access, Valuation, Pricing, and Health Economics, we will able to offer a taylor-made Solution to your specific needs, which will Increase the Value of your Medical Innovation.

  • -Positive and rapid reimbursement
  • -Maximum sales at premium price
  • -Economic value  

HEALTH CARE INNOVATION

  • -MARKET ACCESS & REIMBURSEMENT
  • -PRICING
  • -VALUATION
  • -HEALTH ECONOMICS
    • Pharmacoeconomics
    • Nutritioneconomics
    • Budget impact
  • -STRATEGY
  • -BIOTECHNOLOGY
  • -NUTRITION
  • -PHARMACEUTICALS
  • -DEVICES
  • -E-HEALTH
  • -EUROPE: MULTICOUNTRY MARKET ACCESS AND REIMBURSEMENT
    • UK - NICE and SMC
    • Sweden - TLV
    • Germany - AMNOG
    • Netherlands - Zin
    • Belgium – RIZIV-INAMI
    • Plus rest of Europe
  • -GLOBAL: HEALTH TECJNOLOGY ASSESSMENT AND VALUATION
    • Early phase pricing
    • Valuation

AREAS

GLOBAL + EUROPE